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Abstract
Purpose To investigate the effect of reader experience and zonal location on the occurrence of false positives (FPs) in 
PIRADS (V2) 3, 4, and 5 lesions on multiparametric (MP)-MRI of the prostate.
Materials and methods This retrospective study included 139 patients who had consecutively undergone an MP-MRI of the 
prostate in combination with a transrectal ultrasound MRI fusion-guided biopsy between 2014 and 2017. MRI exams were 
prospectively read by a group of inexperienced radiologists (cohort 1; 54 patients) and an experienced radiologist (cohort 
2; 85 patients). Multivariable logistic regression analysis was performed to determine the association of experience of the 
radiologist and zonal location with a FP reading. FP rates were compared between readings by inexperienced and experienced 
radiologists according to zonal location, using Chi-square (χ2) tests.
Results A total of 168 lesions in 139 patients were detected. Median patient age was 68 years (Interquartile range (IQR) 
62.5–73), and median PSA was 10.9 ng/mL (IQR 7.6–15.9) for the entire patient cohort. According to multivariable logis-
tic regression, inexperience of the radiologist was significantly (P = 0.044, odds ratio 1.927, 95% confidence interval [CI] 
1.017–3.651) and independently associated with a FP reading, while zonal location was not (P = 0.202, odds ratio 1.444, 
95% CI 0.820–2.539). In the transition zone (TZ), the FP rate of the inexperienced radiologists 59% (17/29) was significantly 
higher (χ2 P = 0.033) than that of the experienced radiologist 33% (13/40).
Conclusion Inexperience of the radiologist is significantly and independently associated with a FP reading, while zonal 
location is not. Inexperienced radiologists have a significantly higher FP rate in the TZ.
Keywords MP-MRI · Prostate cancer · PIRADS V2 · Reader experience · Zonal location · False positives
Introduction
Multiparametric (MP) MRI of the prostate is the best option 
for local diagnosis of prostate cancer (PCa) [1–3]. It can 
be useful in various clinical settings, such as for detection 
or staging purposes, guiding biopsies, detection of local 
recurrence, and as a tool to select candidates for active 
surveillance.
A negative transrectal-ultrasound (TRUS)-guided pros-
tate biopsy with persistent clinical suspicion of PCa is still 
the most frequent reason to perform MP-MRI in clinical 
practice. Together with the introduction of the commer-
cially available TRUS-MRI fusion-guided prostate biopsy 
systems, the use of MP-MRI of the prostate has increased 
tremendously over the last years. However, along with 
the increasing popularity of this diagnostic test, serious 
concerns on quality issues have been raised [4, 5]. These 
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quality concerns include image acquisition, interpretation, 
and reporting. The Prostate Imaging Reporting and Data 
System (PIRADS) has been introduced to address some of 
these aforementioned issues. Nonetheless, even with the 
use of the PIRADS version (V) 2 system, interreader vari-
ability is still a common present-day problem [6]. Reader 
experience is probably an important issue in this setting. 
Previous studies have already emphasized the importance 
of subspecialty reading in prostate MRI [7, 8]. Strongly 
related to this subject are the pitfalls encountered on MP-
MRI of the prostate. Awareness of the causes of false 
positives (FPs) can theoretically improve the diagnostic 
performance of the radiologist and decrease interreader 
variability. Besides the experience of the radiologist, zonal 
location can also be a source of FPs [9]. For example, 
detection of PCa in the transition zone (TZ) is often per-
ceived as a difficult task. Pictorial reviews and case series 
have touched on the topic of FPs [10–12], but systematic 
studies specifically investigating FPs in a pure clinical set-
ting are scarce and from the pre-PIRADS era [13]. We 
hypothesized that, when not educated properly, the novice 
reader will, in daily clinical practice, cause unnecessary 
biopsies especially in the TZ.
Therefore, the purpose of this study was to investigate 
the effects of reader experience and zonal location on the 
occurrence of FPs in PIRADS (V2) 3, 4, and 5 lesions on 
MP-MRI of the prostate, with targeted TRUS-MRI fusion-
guided prostate biopsy as reference standard.
Materials and methods
Patients
This retrospective study was approved by the local ethics 
committee, and the need for informed consent was waived 
(registration number 201700780). All patients (n = 186) 
who had consecutively undergone MP-MRI of the prostate 
in combination with a TRUS-MRI fusion-guided prostate 
biopsy between 2014 and 2017 were potentially eligible 
for inclusion. MP-MRI scans of the prostate were either 
obtained from in-house records or from referring centers. 
Patients whose MRI scans were reported before the intro-
duction of standard reporting according to PIRADS version 
2 [14] (n = 38) were excluded. An additional number of 9 
patients were excluded because of missing crucial informa-
tion, such as a PIRADS score (n = 7), inconclusive histopa-
thology report (n = 1), and a history of radiotherapy (n = 1). 
Finally, 139 unique patients were included in this study, of 
whom 54 patients were prospectively read by the inexpe-
rienced radiologists (cohort 1), and 85 patients were read 
by the experienced radiologist (cohort 2) (Fig. 1). 99/139 
patients had undergone prostate MP-MRI because of a pre-
vious history of negative TRUS-guided prostate biopsy and 
persistent clinical suspicion (based on PSA levels and/or 
abnormal digital rectal examination). 41/139 had undergone 
prostate MP-MRI for staging purposes because of increasing 
PSA levels, while being on an active surveillance program 
(inclusion of only low-grade cancers according to PRIAS 
Fig. 1  Flowchart showing the numbers of potentially eligible patients, excluded patients, included patients, and patients scored by inexperienced 
and experienced radiologists
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guidelines (Prostate cancer Research International: Active 
surveillance) [15]).
MRI acquisition and analysis
96 patients were referred from outside hospitals (total of 
9 different institutions), while 43 patients were scanned in 
our institution. In total, 88 exams were performed on a 1.5T 
scanner (of which none was performed with an endorectal 
coil) and 51 exams were performed on a 3T MRI scanner 
(of which 10 with an endorectal coil). Of the 51 exams per-
formed on a 3T scanner, five were primarily scanned on a 
1.5T scanner in outside hospitals. Due to technical limita-
tions (e.g., motion artifacts, inadequate quality), these were 
re-obtained in our institution. The MP-MRI examinations of 
the prostate of 131 patients comprised an axial T1-weighted 
image, a high-resolution multiplanar T2-weighted image 
(slice thickness of 3 mm), a diffusion-weighted image (DWI) 
with at least three b-values (varying between 0-2000 s/mm2 
and with a minimum highest value of 800 s/mm2) and a 
calculated apparent diffusion coefficient (ADC) map, and 
a dynamic contrast-enhanced sequence. The remaining 
8 patients had undergone the same sequences, except for 
a dynamic contrast-enhanced (DCE) sequence. All MRI 
examinations were read at our tertiary referral center. Radi-
ologists were not blinded to clinical data or external reports, 
completely in line with clinical practice. MRI data were read 
prospectively by four different radiologists, with different 
levels of experience in MP-MRI prostate reporting. One 
trained genitourinary radiologist (with 5 years of experi-
ence and > 500 case readings with histopathologic correla-
tion) was defined as the experienced reader, while all other 
three radiologists (with 1–2 years of experience and < 100 
case readings without histopathologic correlation) were 
categorized as inexperienced readers. The MRI scans were 
reported by using PIRADS V2, with PIRADS 1–5 represent-
ing an incremental scoring system of very low likelihood to 
very high likelihood of clinically significant PCa [14]. All 
prostate MRI reports were analyzed for reader experience, 
PIRADS score, and zonal location (peripheral zone (PZ), 
TZ, or central zone (CZ)). Furthermore, the FP lesions were 
retrospectively investigated by the experienced radiologist 
for other sources of error such as known mimickers of PCa 
(e.g., prostatitis, anatomic pitfalls) or possible technical ina-
curacies (e.g., needle delivery, fusion misregistration).
TRUS‑MRI fusion‑guided prostate biopsy
All patients with at least one lesion with a PIRADS score 
of 3 or higher were biopsied according to our institutional 
standard, with up to a maximum of three biopsied lesions 
per patient. The Dynacad Uronav fusion biopsy system 
(Invivo, Gainesville, Florida, USA) was used for all biopsies. 
Targeted biopsies were performed in all patients, while 
two patients also received an additional systematic biopsy. 
Biopsy procedures were undertaken by four different urolo-
gists (with 4, 4, 1, and 1 year(s) of experience with fusion 
biopsy, respectively). The number of cores per lesion was at 
the discretion of the urologist performing the biopsy.
Histopathology
The targeted biopsies were analyzed by a specialist uro-
pathologist according to the International Society of Urolog-
ical Pathology (ISUP) 2014 recommendations [16]. Biopsy 
results containing cancer (Gleason ≥ 3 + 3) were categorized 
as true positives, while the ones containing no cancer were 
categorized as FPs.
Statistical analysis
The Shapiro–Wilk’s test was used to test if the continuous 
variables age, PSA, PSA density, prostate volume, number 
of cancer-suspicious lesions per patient, and number of 
cores taken per patient, were normally distributed. These 
variables were then compared between the patient cohort 
read by the inexperienced radiologists (cohort 1) and the 
patient cohort read by the experienced radiologist (cohort 
2), using the unpaired t test for normally distributed data, 
and the Mann–Whitney U test for not normally distributed 
data. The FP rate was calculated as the number of biopsied 
lesions containing no PCa divided by the total number of 
biopsied lesions. FP rate readings were compared between 
inexperienced and experienced radiologists according to 
zonal location, using Chi-square (χ2) tests. Multivariable 
logistic regression analysis was performed to determine 
the association of the experience of the radiologist (inex-
perienced vs. experienced) and zonal location (TZ vs. PZ) 
with a FP reading. P-values less than 0.05 (two-sided) were 
regarded statistically significant. All statistical analyses were 
performed using MedCalc Statistical Software version 18.5 
(MedCalc Software bvba, Ostend, Belgium).
Results
The 139 included patients had a total of 168 PIRADS 3-5 
lesions. Median patient age was 68 years (interquartile range 
(IQR) 62.5–73) and median PSA was 10.9 ng/mL (IQR 
7.6–15.9) for the entire patient cohort. Age, PSA, PSA den-
sity, prostate volume, number of cancer-suspicious lesions 
per patient, and number of cores taken per patient were not 
significantly different (P > 0.101) between the patient cohort 
read by the inexperienced radiologists and the patient cohort 
read by the experienced radiologist (Table 1).
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The total numbers of PIRADS 3–5 lesions called by the 
inexperienced radiologists and the experienced radiologist 
were 66 (in 54 patients, cohort 1) and 102 (in 85 patients, 
cohort 2), respectively.
110 patients had one lesion, 23 patients had two lesions, 
and 4 patients had three lesions. The inexperienced radiolo-
gists called 29 lesions in the TZ (7 PIRADS 3, 16 PIRADS 
4, 6 PIRADS 5) and 37 lesions in the PZ (4 PIRADS 3, 
20 PIRADS 4, 13 PIRADS 5). The experienced radiologist 
called 40 lesions in the TZ (13 PIRADS 3, 11 PIRADS 4, 
16 PIRADS 5) and 58 lesions in the PZ (7 PIRADS 3, 38 
PIRADS 4, 13 PIRADS 5). Only the experienced radiologist 
called four lesions in the central zone (CZ). Therefore, the 
CZ was excluded from further analysis. In total, 102 biopsies 
(61%) showed PCa (of which 60 (59%) contained clinically 
significant cancer, defined as ≥ 3 + 4 Gleason score), while 
66 biopsies (39%) showed no cancer or benign pathology (of 
which 52 (79%) with normal prostate tissue, 7 (11%) with 
prostatitis, 5 (8%) with prostatic intraepithelial neoplasia 
(PIN), and 2 (3.0%) with PIN and prostatitis).
According to multivariable logistic regression analysis, 
inexperience of the radiologist was significantly (P = 0.044, 
odds ratio 1.927, 95% confidence interval [CI] 1.017–3.651) 
and independently associated with a FP reading, while 
zonal location was not (P =  0.202, odds ratio 1.444, 95% 
CI 0.820–2.539) (Table 2). Overall, FP rate was 50% for 
the inexperienced radiologists, and 32% for the experienced 
radiologist (P = 0.020). The FP rate in the TZ for the inex-
perienced radiologists (59%, 17/29) was significantly higher 
(P = 0.033) than that for the experienced radiologist (33%). 
On the other hand, the FP rate in the PZ for the inexperi-
enced radiologists (43%, 16/37) was not significantly dif-
ferent (P = 0.164) from that for the experienced radiologist 
(29%). Corresponding results are also displayed in Table 3.
After a further breakdown of the 17 FP lesions in the 
TZ for the inexperienced radiologists, all were, retrospec-
tively, perceived to be misclassifications of benign prostatic 
hyperplasia (BPH) nodules (Fig. 2). Of the 16 FP lesions 
in the PZ, 10 could have retrospectively been avoided (e.g., 
anatomic variants of the CZ (Fig. 3), low-grade prostatitis 
with very little-to-no diffusion restriction, BPH nodule in 
PZ). In six cases, a FP reading was perceived as not avoid-
able (3 cases of prostatitis with substantial diffusion restric-
tion mimicking PCa, and 3 cases with, also in retrospect, 
MR imaging abnormalities but with normal histopathology 
results). These latter three cases (9%, 3/33) were interpreted 
Table 1  Characteristics of the 
included patients for the two 
groups of radiologists
a Data presented as median (interquartile range) (not normally distributed according to Shapiro–Wilk test)
b Data presented as mean ± standard deviation (normally distributed according to Shapiro–Wilk test)
c According to Mann–Whitney U test (for not normally distributed independent samples)
Patient cohort 1 read by inexpe-
rienced radiologists 
Total number of patients 54
Total number of lesions 66
Patient cohort 2 read by experi-
enced radiologist 
Total number of patients 85
Total number of lesions 102
P  valuec
Age (years) 70 (65–73)a 67 ± 7.0b 0.101
PSA (ng/mL) 11.6 (7.7–17.0)a 10 (7.3–14.2)a 0.155
PSA density 0.20 ± 0.10b 0.19 (0.14–0.28)b 0.448
Prostate volume (cc) 69 (51–78)a 50 (40–82)a 0.303
Number of cancer-suspi-
cious lesions per patient
1 (1–1)a 1 (1–1)a 0.191
Number of cores taken per 
suspicious lesion
3 (3–4)a 3 (3–3)a 0.824
Table 2  Multivariable logistic regression: relationship of experience 
and zonal location with FP reading
CI confidence interval
Variable Odds ratio (95% CI) P value
Inexperience 1.927 (1.017-3.651) 0.044
Zonal location (transition and 
peripheral zone)
1.444 (0.820-2.539) 0.202
Table 3  FP rate according to reader experience for zonal location and 
PIRADS category
a According to χ2 test






 Transition 59% (17/29) 33% (13/40) 0.033
 Peripheral 43% (16/37) 29% (17/58) 0.164
PIRADS
 3 100% (11/11) 71% (17/24) 0.049
 4 44% (16/36) 27% (13/49) 0.105
 5 32% (6/19) 10% (3/29) 0.059
Overall (PIRADS 3–5) 50% (33/66) 32% (33/102) 0.020
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as likely due to technical inaccuracies (e.g., needle delivery, 
inaccurate fusion of MR, and TRUS images).
For the experienced radiologist, of the 13 FP lesions 
in the TZ, 6 were perceived as misclassifications (of BPH 
nodules and prominent anterior fibromuscular stroma). 
Two were prospectively called as granulomateus prostati-
tis (however, biopsy was still advised), five were perceived 
as MR imaging abnormalities but with normal histopa-
thology results. Of the 17 FP lesions in the PZ, five were 
high-grade PIN and/or prostatitis,  and two were perceived 
as misclassifications (very little diffusion restriction). 
Ten were perceived, also in retrospect, as MR imaging 
abnormalities, but with normal histopathology results. 
Fig. 2  74-year-old patient, with a PSA of 28 ng/mL and a history of 
previous negative transrectal-ultrasound-guided biopsy. PSA density 
of 0.13. Pitfall of benign prostatic hyperplasia nodule in the transition 
zone. Histopathology result revealed benign changes, no malignancy. 
a T2-weighted image with a PIRADS 4 lesion (straight arrow) on 
the initial read, reported by an inexperienced radiologist. This lesion 
was retrospectively perceived as an example of a misclassification of 
a benign prostatic hyperplasia nodule in the transition zone, which 
should have been classified as a PIRADS 2 lesion. b Apparent diffu-
sion coefficient map with the false positive lesion (straight arrow). c 
Dynamic contrast-enhanced image, slightly asymmetric enhancement 
(straight arrow)
Fig. 3  72-year-old patient, with a PSA of 12 ng/mL and a history of 
previous negative transrectal-ultrasound-guided biopsy. PSA density 
of 0.19. Classic pitfall of the central zone compressed between the 
transition zone and peripheral zone. Histopathology result revealed 
normal tissue, no malignancy, prostatic intraepithelial neoplasia or 
prostatitis. a T2-weighted image with a PIRADS 4 lesion (straight 
arrow) on the initial read, reported by an inexperienced radiologist. 
This lesion was retrospectively perceived as an example of a misclas-
sification of an anatomic variant of the central zone. b Apparent dif-
fusion coefficient map with the false positive lesion (straight arrow). 
c Dynamic contrast-enhanced image, with no contrast enhancement 
(straight arrow)
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Altogether for both the TZ and PZ, 15 (50%, 15/30) FP 
lesions were likely due to technical inaccuracies.
Discussion
To our knowledge, this study is the first to investigate the 
FP findings of PIRADS (V2) 3-5 lesions in a pure clini-
cal setting with emphasis on reader experience and zonal 
location, in a patient population undergoing TRUS MRI 
fusion-guided targeted prostate biopsy. Our results show that 
inexperience is independently and significantly associated 
with a FP reading while zonal location is not. Furthermore, 
the evaluation of the TZ is mainly what makes the differ-
ence between the inexperienced and experienced radiologist. 
In general, the TZ is an anatomic area that is considered 
difficult when interpreting MP-MRI of the prostate. The 
challenging aspect of detecting PCa in the TZ is probably 
because of the heterogeneous appearance of the TZ which 
is mainly due to the BPH it contains. Our study shows that 
the evaluation of the TZ is even more difficult for the inex-
perienced radiologist. We also found that, to a lesser degree, 
other potential sources of a FP reading for the inexperienced 
reader are anatomic variants of the CZ and low-grade prosta-
titis. One of the main advantages of MP-MRI is its potential 
to reduce unnecessary biopsies [17, 18]. Nonetheless, in case 
of an inexperienced radiologist and a suspected TZ lesion, 
this could lead to more unnecessary biopsies. The PIRADS 
3 classification had a high number of FPs, for both the inex-
perienced and the experienced radiologists. Even though this 
is likely to be expected as PIRADS is a Likert scale, efforts 
for reducing the number of unnecessary biopsies in this spe-
cific group should be made. A possible solution could be 
the addition of PSA density [19]. Consequently, all lesions 
with a PIRADS score of 3 and a cut off value of for example 
below 0.15 could be refrained from biopsy. However, before 
implementation this needs to be investigated further with 
special attention to the number of missed significant cancers 
with this approach. Also noteworthy, FP rates do not only 
depend on factors accountable to the reader, but also on inac-
curacies related to the biopsy technique itself, most likely in 
case of smaller lesions [20–22]. Nonetheless, when analyz-
ing the FPs in the patient cohort of this study that were read 
by the inexperienced radiologists the majority appeared to be 
classical examples of misclassification for the TZ as well as 
for the PZ. In our study, we found that only in 9% of the FP 
cases for the inexperienced radiologists and in 50% of the FP 
cases for the experienced radiologist technical issues could 
have been the reason for a FP lesion. A study by Sheriden 
et al. [23] reported that 28% of the FP PIRADS 5 lesions 
could have been missed at biopsy. The difference with our 
study is that they only investigated PIRADS 5 lesions that 
are usually large and therefore technique-wise less likely 
to be missed at biopsy. The findings of this study have two 
potential clinical implications. First, the relative underper-
formance of inexperienced readers underlines that reading 
MP-MRI of the prostate should be reserved to experienced 
radiologists. The importance of subspecialty training is a 
well-acknowledged issue in breast and cardiac imaging. This 
should not be different for MRI of the prostate. After internal 
evaluation of the results of this study, we decided to reduce 
the number of radiologists reporting MP-MRI of the prostate 
and educate internally. Since then, only two of six special-
ized abdominal radiologists have been reporting MP-MRI of 
the prostate at our institution. The second potential implica-
tion of our findings is that training sessions for inexperi-
enced radiologists should, along with a sufficient caseload 
with histopathological correlation, pay special attention to 
the TZ [24, 25], CZ, and low-grade prostatitis.
The overall detection (or true positive) rate of the expe-
rienced reader in this study (68% overall detection rate 
in PIRADS 3-5 lesions) was slightly higher than other 
expert centers performing MRI targeted prostate biopsy 
(59%–62%) [26, 27]; however, both studies were performed 
using PIRADS V1 which could also have accounted for 
the slight differences. In 2013, Bratan et al. [13] were the 
first to investigate the FPs. However, this publication was 
from the pre-PIRADS era, and they did not assess different 
levels of experience. In another study published in 2017, 
the issue of experience was addressed [5]. They reported 
that reader experience may help to reduce overcalling and 
avoid over targeting of lesions, which is in concordance with 
our results. Nevertheless, none of these studies specifically 
looked at the combination of reader experience and zonal 
location in FP lesions.
Our study had several limitations. First, because of its 
retrospective design, MRI protocols were heterogeneous 
(i.e., different magnetic field strengths and slightly vary-
ing MRI sequence settings), and possibly of suboptimal 
quality (e.g., majority of scans were obtained with a 1.5T 
scanner; and no endorectal coil or the inability to control 
imaging parameters due to referrals from outside hospi-
tals). However, this is completely in line with routine clini-
cal practice, and this issue is also frequently encountered 
in multicenter studies [5, 18], which in fact increases the 
generalizability of our results. Second, we were not able to 
analyze false negatives and their relation to reader experi-
ence, which could have been done if the reference stand-
ard would have been prostatectomy specimens or if long-
term follow-up data would have been available. Third, this 
study did not investigate other factors potentially asso-
ciated with a FP reading, such as clinical variables and 
apex-base location [23]. Fourth, this study consisted of 
patients who had received prior biopsy (either negative or 
with cancer but on active surveillance) possibly reducing 
the future generalizability of the results. It is expected 
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that as we move forward, more biopsy-naïve patients will 
undergo MP-MRI and targeted biopsy. Fifth, we did not 
include Gleason 3 + 3 lesions in our FP definition. In the 
era of the increasing number of active surveillance candi-
dates, we are well aware of the importance of being able 
to discriminate between clinically significant (currently 
regarded as Gleason ≥ 3 + 4) and insignificant PCa (cur-
rently regarded as Gleason ≤ 3 + 3). However, including 
3 + 3 in the FP definition on MP-MRI would, unfairly, 
imply that there are proven MRI features that are prospec-
tively able to discriminate Gleason 3 + 3 from 3 + 4. There 
are retrospective and validation studies that have investi-
gated the relationship between ADC values and Gleason 
grades, and they have shown promising results [28]. Yet 
substantial overlaps between the different grades and ADC 
values exist [28], making it not very useful in a clinical 
setting. Due to the lack of robust discriminatory imaging 
features, publications addressing pitfalls on prostate MRI 
usually only contain examples of benign disease or FPs 
related to more technical issues [10, 11]. Likewise, the 
clinically important decision between Gleason 3 + 3 and 
3 + 4 can also be challenging on histopathology slides in 
biopsy specimens. There is substantial interobserver vari-
ability together with shortcomings of the Gleason grading 
scoring system itself [29]. This is probably also the reason 
why some supposedly Gleason 3 + 3 tumors, even though 
not very common, can metastasize or show aggressive 
behavior (such as extraprostatic extension or even seminal 
vesical invasion) [30, 31]. Furthermore, targeted biopsies 
obtained from the cancer-suspicious lesions detected on 
MP-MRI might not accurately represent the true aggres-
siveness found in a prostatectomy specimen [32–34], with 
some studies even mentioning percentages of upgrading 
from 3 + 3 to 3 + 4 in 67.4% of the cases [32]. So even 
though there is an absolute clinical need for discriminat-
ing significant from insignificant PCa, it is radiologically 
not meaningful when assessing FPs. Future studies should 
focus on this unsolved issue.
In conclusion, inexperience of the radiologist is sig-
nificantly and independently associated with a FP read-
ing, while zonal location is not. Inexperienced radiologists 
have a significantly higher FP rate in the TZ.
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